BP-5-087 is a STAT3 inhibitor used in chronic myeloid leukemia (CML) research. It is investigated in vitro and in vivo to overcome kinase-independent resistance when combined with BCR-ABL1 targeted therapies, addressing a key challenge in CML treatment.
Molecular Weight:
770.69
CAS Number:
[1803281-30-2]
Formula:
C36H30F8N2O6S
Target:
STAT,Others
* VAT and and shipping costs not included. Errors and price changes excepted